SIGN UPLog In

General

Financials

People

Activity

Recent News
Sangart
Sangart
Company

Last deal

$50M

Amount

Series G

Stage

24.05.2012

Date

3

all rounds

$294.45M

Total amount

date founded

Financing round

General

About Company
Sangart, Inc. is a biopharmaceutical company specializing in oxygen-therapeutic agents.

Industry

Sector :

Subsector :

founded date

01.01.1998

Number of employees

51-100

Company Type

For Profit

Last funding type

Series G

IPO status

Private

Description

Founded in 1998, Sangart focuses on researching, developing, and commercializing innovative oxygen transport agents. With over two decades of research in red blood cell substitutes and cell-free hemoglobin solutions, Sangart aims to be the global leader in providing oxygen-therapeutic products to patients in need.
Contacts

location

San Diego, CA, USA

Phone number

Website URL

http://www.sangart.com
Similar Companies
998
Ception Therapeutics
Ception TherapeuticsCeption Therapeutics is a biopharmaceutical company developing novel products to address areas of unmet medical needs.
Ception Therapeutics

Ception Therapeutics

Ception Therapeutics is a biopharmaceutical company developing novel products to address areas of unmet medical needs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Malvern, PA 19355, USA

total rounds

2

total raised

$77.7M
Trevena
TrevenaTrevena is a clinical stage biopharmaceutical company that develops G-protein coupled receptors biased ligands..
Trevena

Trevena

Trevena is a clinical stage biopharmaceutical company that develops G-protein coupled receptors biased ligands..

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

King of Prussia, PA, USA

total rounds

19

total raised

$548.58M
Tigris Pharmaceuticals
Tigris PharmaceuticalsTigris Pharmaceuticals develops therapeutic technologies for oncology and other medical needs.
Tigris Pharmaceuticals

Tigris Pharmaceuticals

Tigris Pharmaceuticals develops therapeutic technologies for oncology and other medical needs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Bonita Springs, FL, USA

total rounds

3

total raised

$32.49M
BiolineRx
BiolineRxBioLineRx is a clinical-stage biopharmaceutical company based in Jerusalem, Israel, focused on developing innovative cancer therapies.
BiolineRx

BiolineRx

BioLineRx is a clinical-stage biopharmaceutical company based in Jerusalem, Israel, focused on developing innovative cancer therapies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Jerusalem, Israel

total rounds

17

total raised

$257.74M

Financials

Funding Rounds
10
3

Number of Funding Rounds

$294.45M

Money Raised

Their latest funding was raised on 24.05.2012. Their latest investor Jefferies Financial Group. Their latest round Series G

Date 
Funding Round 
Investors 
Money Raised 
Lead 
24.05.2012
Series G
1
$50M
Jefferies Financial Group
Jefferies Financial Group
19.04.2011
Venture - Series Unknown
1
$50M
Jefferies Financial Group
Jefferies Financial Group
13.10.2010
Venture - Series Unknown
—
$15.1M
—
Jefferies Financial Group

Jefferies Financial Group

Jefferies Financial Group is a diversified financial services company focused on investment banking, merchant banking, and asset management.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Banking, Finance

Location

New York, NY, USA

total rounds

3

total raised

$2.5B

count Of Investments

20

count Of Exists

3
Jefferies Financial Group

Jefferies Financial Group

Jefferies Financial Group is a diversified financial services company focused on investment banking, merchant banking, and asset management.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Banking, Finance

Location

New York, NY, USA

total rounds

3

total raised

$2.5B

count Of Investments

20

count Of Exists

3
Co-Investors
Investors
2
1

Number of lead investors

2

Number of investors

Investor 
Lead 
Round 
Partners 
Jefferies Financial Group
Jefferies Financial Group
Yes
Series F, Series G, Venture - Series Unknown
—
ODIN Forvaltning
ODIN Forvaltning
No
Venture - Series Unknown
—
Jefferies Financial Group

Jefferies Financial Group

Jefferies Financial Group is a diversified financial services company focused on investment banking, merchant banking, and asset management.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Banking, Finance

Location

New York, NY, USA

total rounds

3

total raised

$2.5B

count Of Investments

20

count Of Exists

3
ODIN Forvaltning

ODIN Forvaltning

ODIN Forvaltning is a Norwegian investment advisor that invests globally, with a focus on the United States.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Oslo, Norway

count Of Investments

1

People

Employee Profiles
7
David Renas
David Renas

David Renas

Chief Financial Officer and General Counsel

Chief Financial Officer and General Counsel

Carmen Betancourt-RIche
Carmen Betancourt-RIche

Carmen Betancourt-RIche

Vice President of Regulatory Affairs and Quality Assurance

Vice President of Regulatory Affairs and Quality Assurance

Kenneth E. Burhop

Kenneth E. Burhop

Chief Scientific Officer

Chief Scientific Officer

Brian O'Callaghan
Brian O'Callaghan

Brian O'Callaghan

President and Chief Executive Officer

President and Chief Executive Officer

Clive Bertram
Clive Bertram

Clive Bertram

Chief Commercial Officer

Chief Commercial Officer

Kristine Figueroa

Kristine Figueroa

Vice President of Human Resources

Vice President of Human Resources

Activity

Recent News
0